Tag: Oncopeptides AB

Home / Oncopeptides AB

Categories

Melphalan flufenamide receives approval from the FDA for relapsed or refractory multiple myeloma

August 2021: Melphalan flufenamide (Pepaxto, Oncopeptides AB) in combination with dexamethasone has been granted accelerated approval by the Food and Drug Administration for adult patients with relaps...
oncopeptides-ab

Scan the code